Linkedin-in Facebook-f
Our Portfolio Companies
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Briefcase Loading...

Dr. Itzik Goldwaser Named Yissum Ceo

  • December 24, 2019

December 24, 2019 – Jerusalem: Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that Dr. Itzik Goldwaser will succeed Dr. Yaron Daniely as CEO of Yissum.

“I feel privileged to become Yissum’s CEO and am looking forward to deepening the relationships between industry and academia, maximizing the huge potential of the Hebrew University’s know-how, and adding value, together with Yissum’s outstanding team,” said Dr. Goldwaser. “I’ve been with Yissum for almost ten years and have a keen appreciation for the vital role technology transfer plays in bringing innovation to the marketplace and to where it will have the greatest impact.”

Dr. Goldwaser has been with Yissum since 2010, most recently serving as its SVP of Business Development & Alliance Management. He has over 25 years of experience in the biopharmaceutical industry, spanning executive and R&D management roles in the biotechnology, chemical, and biological drug development markets. Before coming to Yissum, he held a number of leadership positions, including Co-Founder, CEO, President of NasVax, and CTO of Sol-Gel Technologies.

About Yissum
Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the third company of its kind to be established and serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry. Yissum’s mission is to benefit society by converting extraordinary innovations and transformational technologies into commercial solutions that address our most urgent global challenges. Yissum has registered over 10,000 patents covering 2,800 inventions; licensed over 900 technologies and has spun out more than 170 companies. Yissum’s business partners span the globe and include companies such as Boston Scientific, Google, ICL, Intel, Johnson & Johnson, Merck, Microsoft, Novartis and many more. For further information please visit www.yissum.co.il

Contact: Estee Yaari, Yissum Media Relations, [email protected]

Latest

Startup Vitalunga creates novel oral drug to enable disease-free aging; preclinical studies expected to begin in near future

May 25, 2022
The Hebrew University Portfolio Company addresses modern medicine’s number one problem: extending lifespan without disease and has the potential to improve quality of life for the world’s rapidly growing aging population….

Hebrew University Team Announces Creation of Shape-Shifting Pasta to Revolutionize the Packaging Industry

March 31, 2022
The pasta, which transforms from flat to popular shapes upon boiling, is highly unique and could cut down on packaging costs and carbon dioxide emissions for manufacturers….

Yissum Technology Transfer Announces 15 New Companies

January 20, 2022
The new batch of promising startups backed by The Hebrew University of Jerusalem’s Technology Transfer includes next-generation tech spanning MRNA, genetics, delivery methods, and other pharma advancements, alongside next-gen solar technology….
ADDRESS

Hi-Tech Park, Edmond J. Safra
Campus, Bungalow 2.6
Givat-Ram, Jerusalem
P.O. Box 39135
91390 Israel

CONTACT US
  • Phone: +972-2-658-6688
  • Fax: +972-2-658-6689
  • Email: [email protected]
FOLLOW US
Twitter Linkedin-in Facebook-f Youtube
COPYRIGHT
Twitter Linkedin-in Facebook-f Youtube
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Search Our Technologies
Find a Research Expert
Our Portfolio Companies
Briefcase Loading...